Malignant Iris Neoplasm — Trials

Malignant Iris Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02336763	Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver Metastases	terminated	N/A	2	Jonsson Comprehensive Cancer CenterOTHER	1	Jul 24, 2020	clinicaltrials
NCT01730157	Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases	terminated	Early Phase 1	6	Case Comprehensive Cancer CenterOTHER	1	Mar 10, 2016